TY - JOUR
T1 - Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training
AU - Negi, Smita I.
AU - Steinberg, Lynne
AU - Polsani, Venkateshwar R.
AU - Gowani, Saqib A.
AU - Nambi, Vijay
AU - Kumar, Varinder
AU - Marinescu, Victor
AU - Jones, Peter H.
AU - Petersen, Laura A.
AU - Ballantyne, Christie M.
AU - Virani, Salim S.
N1 - Funding Information:
This work was supported by Investigator Initiated Research funding by Merck and Co, Inc (II SP 37267). Dr. Virani is supported by a Department of Veterans Affairs Health Services Research and Development Service Career Development Award (CDA 09-028). Dr. Nambi is supported by a NIH-Career Development Grant (K23 HL096893).
PY - 2012/1
Y1 - 2012/1
N2 - Background: Non-high density lipoprotein cholesterol (non-HDL-C) goal attainment per Adult Treatment Panel III (ATP III) guidelines remains low. Objective: To understand gaps in knowledge and practices of physicians-in- training (internal medicine, family medicine, cardiology, endocrinology) towards non-HDL-C. Methods: A survey based on a conceptual model to assess the trainee's knowledge, attitudes, and practice regarding non-HDL-C was developed and administered to physicians-in-training (n = 655) at 26 training programs in the United States. Responses of those in internal medicine and family medicine (residents-in-training; n = 418) were compared with those in cardiology and endocrinology (fellows-in-training; n = 124). Results: Response rate was 83.7%. Fifty-three percent of residents and 31% of fellows-in-training had not read the ATP III guidelines (P <.001). Thirty-three percent of the residents and 35% fellows-in-training could not calculate non-HDL-C from a standard lipid panel (P =.7). Sixty-seven percent of the residents and 52% of fellows were not aware of treatment goals for non-HDL-C (P =.004 for comparison between residents and fellows). Both residents and fellows reported infrequent calculation of non-HDL-C levels in patients with elevated triglycerides (≥200 mg/dL; 32.5% vs 35.4%, respectively, P =.6). Lack of familiarity with ATP III guidelines, lack of knowledge regarding importance of non-HDL-C, lack of institutional mandate to calculate non-HDL-C, and lack of emphasis on non-HDL-C by teaching staff were reported as barriers to non-HDL-C use in routine clinical practice. Conclusions: At least one-third of physicians-in-training could not calculate non-HDL-C from a standard lipid panel, and a large number were not aware of ATP III treatment goals pertaining to non-HDL-C. This area represents one for improvement if non-HDL-C is to be retained as a treatment target in the forthcoming ATP-IV guidelines.
AB - Background: Non-high density lipoprotein cholesterol (non-HDL-C) goal attainment per Adult Treatment Panel III (ATP III) guidelines remains low. Objective: To understand gaps in knowledge and practices of physicians-in- training (internal medicine, family medicine, cardiology, endocrinology) towards non-HDL-C. Methods: A survey based on a conceptual model to assess the trainee's knowledge, attitudes, and practice regarding non-HDL-C was developed and administered to physicians-in-training (n = 655) at 26 training programs in the United States. Responses of those in internal medicine and family medicine (residents-in-training; n = 418) were compared with those in cardiology and endocrinology (fellows-in-training; n = 124). Results: Response rate was 83.7%. Fifty-three percent of residents and 31% of fellows-in-training had not read the ATP III guidelines (P <.001). Thirty-three percent of the residents and 35% fellows-in-training could not calculate non-HDL-C from a standard lipid panel (P =.7). Sixty-seven percent of the residents and 52% of fellows were not aware of treatment goals for non-HDL-C (P =.004 for comparison between residents and fellows). Both residents and fellows reported infrequent calculation of non-HDL-C levels in patients with elevated triglycerides (≥200 mg/dL; 32.5% vs 35.4%, respectively, P =.6). Lack of familiarity with ATP III guidelines, lack of knowledge regarding importance of non-HDL-C, lack of institutional mandate to calculate non-HDL-C, and lack of emphasis on non-HDL-C by teaching staff were reported as barriers to non-HDL-C use in routine clinical practice. Conclusions: At least one-third of physicians-in-training could not calculate non-HDL-C from a standard lipid panel, and a large number were not aware of ATP III treatment goals pertaining to non-HDL-C. This area represents one for improvement if non-HDL-C is to be retained as a treatment target in the forthcoming ATP-IV guidelines.
KW - Adult Treatment Panel guidelines
KW - Non-HDL-C calculation
KW - Non-HDL-C goals
KW - Physicians-in-training
UR - https://www.scopus.com/pages/publications/84856232131
U2 - 10.1016/j.jacl.2011.10.020
DO - 10.1016/j.jacl.2011.10.020
M3 - Article
C2 - 22264574
AN - SCOPUS:84856232131
SN - 1933-2874
VL - 6
SP - 50
EP - 57
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
IS - 1
ER -
